Nexo Therapeutics, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Mar 27, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Sep 17, 2025 · D/A | Mar 27, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $60,000,000 | $60,000,000 | $0 |
| Reported amount sold | $52,500,001 | $60,000,000 | $7,499,999 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001955319-25-000002 · Later SEC source: 0001955319-26-000001
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $60,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $60,000,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001955319-26-000001D/A · Mar 27, 2026 · BiotechnologyOffering: $60,000,000Sold: $60,000,000
Compared with 0001955319-25-000002:
- Reported amount sold: $52,500,001 → $60,000,000
-
0001955319-25-000002D/A · Sep 17, 2025 · BiotechnologyOffering: $60,000,000Sold: $52,500,001